These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21073364)

  • 1. Aldosterone antagonists--last man standing?
    Armstrong PW
    N Engl J Med; 2011 Jan; 364(1):79-80. PubMed ID: 21073364
    [No Abstract]   [Full Text] [Related]  

  • 2. Eplerenone in mild heart failure.
    Tomaschitz A; Pilz S; März W
    N Engl J Med; 2011 Apr; 364(14):1371; author reply 1372. PubMed ID: 21470018
    [No Abstract]   [Full Text] [Related]  

  • 3. Eplerenone in mild heart failure.
    Gus M; Fuchs FD
    N Engl J Med; 2011 Apr; 364(14):1370-1; author reply 1372. PubMed ID: 21470019
    [No Abstract]   [Full Text] [Related]  

  • 4. Mineralocorticoid receptor antagonists for heart failure.
    Funder J
    Expert Opin Pharmacother; 2011 Dec; 12(18):2767-9. PubMed ID: 22098225
    [No Abstract]   [Full Text] [Related]  

  • 5. Eplerenone in patients with systolic heart failure and mild symptoms.
    Zannad F; McMurray JJ; Krum H; van Veldhuisen DJ; Swedberg K; Shi H; Vincent J; Pocock SJ; Pitt B;
    N Engl J Med; 2011 Jan; 364(1):11-21. PubMed ID: 21073363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone blockade and heart failure.
    Jessup M
    N Engl J Med; 2003 Apr; 348(14):1380-2. PubMed ID: 12668698
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade.
    Dawson A; Davies JI; Struthers AD
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):29-36. PubMed ID: 15038411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aldosterone and aldosterone-receptor antagonists in heart failure.
    Khan NU; Movahed A
    Rev Cardiovasc Med; 2004; 5(2):71-81. PubMed ID: 15184841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of aldosterone antagonists in the cardiovascular diseases].
    Trzaska E; Gumułka W; Makulska-Nowak HE
    Kardiol Pol; 2009 Jun; 67(6):667-71. PubMed ID: 19618325
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of aldosterone receptor blockade in the management of cardiovascular disease.
    Liew D; Krum H
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in heart failure 2011.
    Gaddam KK; Ventura H
    Congest Heart Fail; 2012; 18(2):112-26. PubMed ID: 22432558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone receptor blockade: a therapy resurrected.
    Sica DA
    Heart Dis; 2003; 5(2):85-8. PubMed ID: 12713674
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aldosterone antagonists for all patients with heart failure?].
    Bauersachs J
    MMW Fortschr Med; 2009 Apr; 151(15):33-5. PubMed ID: 19728679
    [No Abstract]   [Full Text] [Related]  

  • 14. Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION.
    Teerlink JR; Massie BM;
    J Card Fail; 2003 Jun; 9(3):158-63. PubMed ID: 12815564
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aldosterone receptor antagonists in heart failure. Rightly brought back from retirement].
    Kolloch R; Offers E
    MMW Fortschr Med; 2003 Nov; 145(47):42-4, 47. PubMed ID: 14725033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues.
    Kalidindi SR; Tang WH; Francis GS
    Nat Clin Pract Cardiovasc Med; 2007 Jul; 4(7):368-78. PubMed ID: 17589427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
    Capuano A; Scavone C; Vitale C; Sportiello L; Rossi F; Rosano GM; Coats AJ
    Int J Cardiol; 2015 Dec; 200():15-9. PubMed ID: 26404747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of aldosterone receptor antagonists in the management of heart failure: an update.
    Nagarajan V; Chamsi-Pasha M; Tang WH
    Cleve Clin J Med; 2012 Sep; 79(9):631-9. PubMed ID: 22949344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
    Ajani AE; Marwick TH; Krum H
    Cardiovasc Revasc Med; 2006; 7(4):234-6. PubMed ID: 17174870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.